Cart summary

You have no items in your shopping cart.

BMH-21

SKU: orb1223725

Description

BMH-21 is a RNA polymerase I inhibitor with wide and potent antitumorigenic activity across NCI60 cancer cell lines with mean GI50 of 160 nM, interacts with GC-Rich rDNA, potently and rapidly represses RNA polymerase I (Pol I) transcription; inhibits the expression of 47S rRNA transcript with IC50 of 60 nM, blocks transcription of the rRNA precursor without affecting rRNA maturation, and causes segregation of nucleolar proteins; causes proteasome-mediated degradation of RPA194 (Pol I catalytic subunit); activates p53 and inhibits TP53 null and mutant cell lines with GI50 of 110 and 205 nM, respectively.

Images & Validation

Key Properties

CAS Number896705-16-1
MW360.4091
Purity>98% (HPLC)
FormulaC21H20N4O2
SMILESO=C(C1=CC=CN2C1=NC3C=C(C=CC=C4)C4=CC3C2=O)NCCN(C)C
TargetDNA/RNA Synthesis
Solubility10 mM in DMSO

Bioactivity

In Vivo
BMH-21 (50 mg/kg; i.p.; daily; for 6 days) inhibits HCT116 colon cancer tumor growth In vivo. Animal model: 6-week old athymic NCr nu/nu mice, with HCT116 colorectal carcinoma xenograft. Dosage: 50 mg/kg. Administration: Intraperitoneal injection, daily, for 6 days. Result: Significantly inhibited HCT116 colon cancer tumor growth.
In Vitro
BMH-21 binds ribosomal DNA and inhibits Pol I transcription. BMH-21 inhibits RNA polymerase I independent of DNA damage response. BMH-21 intercalates into double strand (ds) DNA and has binding preference towards GC-rich DNA sequences. BMH-21 (1 μM; 3 hours) acts in a DNA damage independent manner to activate nucleolar stress and RPA194 degradation. Cell Viability Assay Cell line: U2OS cells. Concentration: 0 μM, 0.1 μM, 1 μM, 10 μM Incubation time: 48 hours. Result: Decreased the viability of cells at concentrations that activated the DNA damage response. Western blot analysis. Cell line: A375 cells. Concentration: 1 μM. Incubation time: 3 hours. Result: Degraded RPA194 with blocked ATM and DNA-PKcs activity.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

BMH21

Similar Products

  • BMH-21 [orb1307493]

    99.84% (May vary between batches)

    896705-16-1

    360.41

    C21H20N4O2

    10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

BMH-21 (orb1223725)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

500 mg
5 mg
$ 80.00
10 mg
$ 100.00
25 mg
$ 160.00
50 mg
$ 240.00
100 mg
$ 400.00
200 mg
$ 580.00